US Senator Calls Out Big Pharma Over Improper Inhaler Patents

AstraZeneca, Boehringer Ingelheim, GSK And Teva Urged To Remove Patents From Orange Book

Hand holding blue inhaler on orange background
The FTC challenged over 100 patents last year • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin